Patents by Inventor Melanie SNO
Melanie SNO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11654191Abstract: The present invention pertains to a vaccine comprising in combination non-replicating immunogen of porcine circo virus type 2 and live attenuated PRRS virus for use in prophylactically treating an animal against an infection with porcine circovirus type 2 (PCV2) and an infection with PRRS virus by administration of the vaccine into the dermis of the animal.Type: GrantFiled: March 22, 2017Date of Patent: May 23, 2023Assignee: Intervet Inc.Inventors: Melanie Sno, Maarten Hendrik Witvliet, Vicky Fachinger
-
Publication number: 20220323567Abstract: The present invention relates to the field of veterinary vaccinology, namely to combination vaccines for swine. In particular the invention relates to a combination vaccine for protection against a pathogenic infection with porcine circo vims type 2 (PCV2) and Mycoplasma hyopneumoniae (Mhyo) comprising non-replicating immunogen of PCV2 and non-replicating immunogen of Mhyo. The vaccine is characterized in that it is an oil-in-water emulsion comprising squalane, vitamin E-acetate and silica. In another embodiment, the invention relates to a combination vaccine for protection against a pathogenic infection with PCV2 and Mhyo by intradermal administration.Type: ApplicationFiled: September 11, 2020Publication date: October 13, 2022Inventors: Theodorus Jansen, Melanie SNO, Martin PIEST
-
Patent number: 11311614Abstract: The present invention pertains to a combination of a first vaccine comprising non-replicating immunogen of porcine circo virus type 2 (PCV2) and non-replicating immunogen of Mycoplasma hyopneumoniae, and a second vaccine comprising live attenuated porcine reproductive and respiratory syndrome (PRRS) virus, for use in prophylactically treating an animal against an infection with porcine circovirus type 2, an infection with Mycoplasma hyopneumoniae and an infection with PRRS virus, by associated non-mixed administration of the first vaccine and the second vaccine to the animal. The invention also pertains to a kit-of-parts comprising the first and second vaccine and to a method of protecting an animal against such infections using these vaccines.Type: GrantFiled: April 12, 2018Date of Patent: April 26, 2022Assignee: Intervet Inc.Inventors: Maarten Hendrik Witvliet, Erwin van den Born, Melanie Sno, Antonius Arnoldus Christiaan Jacobs
-
Patent number: 11135285Abstract: The invention pertains to a vaccine comprising in combination non-replicating immunogens of Erysipelothrix rhusiopathiae, porcine parvo virus, Leptospira interrogans and live attenuated PRRS virus, and a pharmaceutically acceptable carrier, for use in a method for prophylactic treatment of a swine against an infection with Erysipelothrix rhusiopathiae, porcine parvo virus, Leptospira interrogans and PRRS virus, wherein the vaccine is administered in a single dose with regard to the treatment against an infection with PRRS virus.Type: GrantFiled: November 28, 2017Date of Patent: October 5, 2021Assignee: Intervet Inc.Inventors: Erwin Born van den, Antonius Arnoldus Christiaan Jacobs, Melanie Sno
-
Patent number: 11077181Abstract: The present invention pertains to a vaccine comprising an ORF2 encoded protein of porcine circo virus 2 (PCV2) and a pharmaceutically acceptable carrier, for use in a method to protect a pig against an infection with porcine circo virus type 2 by administering the vaccine to the pig, wherein the vaccine comprises less than 20 ?g per dose of the ORF2 encoded protein, the protein being of a porcine circo virus of genotype 2b.Type: GrantFiled: August 2, 2018Date of Patent: August 3, 2021Assignee: Intervet Inc.Inventors: Melanie Sno, Erik Cox, Ruud Philip Antoon Maria Segers
-
Patent number: 10953084Abstract: The present invention pertains to a vaccine for use in prophylactically treating an animal against an infection with porcine circovirus type 2 (PCV2) and an infection with PRRS virus, the vaccine comprising in combination non-replicating immunogen of porcine circovirus type 2 and live attenuated PRRS virus, wherein the vaccine additionally comprises albumin.Type: GrantFiled: March 22, 2017Date of Patent: March 23, 2021Assignee: Intervet Inc.Inventors: Melanie Sno, Pieter Van Gelder, Vicky Fachinger, Chen Shu-hui Tan
-
Publication number: 20200384102Abstract: The invention pertains to a vaccine comprising in combination non-replicating immunogens of Erysipelothrix rhusiopathiae, porcine parvo virus, Leptospira interrogans and live attenuated PRRS virus, and a pharmaceutically acceptable carrier, for use in a method for prophylactic treatment of a swine against an infection with Erysipelothrix rhusiopathiae, porcine parvo virus, Leptospira interrogans and PRRS virus, wherein the vaccine is administered in a single dose with regard to the treatment against an infection with PRRS virus.Type: ApplicationFiled: November 28, 2017Publication date: December 10, 2020Applicant: Intervet Inc.Inventors: Erwin Born van den, Antonius Arnoldus Christiaan Jacobs, Melanie Sno
-
Publication number: 20200206340Abstract: The present invention pertains to a vaccine comprising an ORF2 encoded protein of porcine circo virus 2 (PCV2) and a pharmaceutically acceptable carrier, for use in a method to protect a pig against an infection with porcine circo virus type 2 by administering the vaccine to the pig, wherein the vaccine comprises less than 20 ?g per dose of the ORF2 encoded protein, the protein being of a porcine circo virus of genotype 2b.Type: ApplicationFiled: August 2, 2018Publication date: July 2, 2020Applicant: Intervet Inc.Inventors: Melanie SNO, Erik COX, Ruud Philip Antoon Maria SEGERS
-
Publication number: 20200046825Abstract: The present invention pertains to a combination of a first vaccine comprising non-replicating immunogen of porcine circo virus type 2 (PCV2) and non-replicating immunogen of Mycoplasma hyopneumoniae, and a second vaccine comprising live attenuated porcine reproductive and respiratory syndrome (PRRS) virus, for use in prophylactically treating an animal against an infection with porcine circovirus type 2, an infection with Mycoplasma hyopneumoniae and an infection with PRRS virus, by associated non-mixed administration of the first vaccine and the second vaccine to the animal. The invention also pertains to a kit-of-parts comprising the first and second vaccine and to a method of protecting an animal against such infections using these vaccines.Type: ApplicationFiled: April 12, 2018Publication date: February 13, 2020Applicant: Intervet Inc.Inventors: Maarten Hendrik WITVLIET, Erwin van den BORN, Melanie SNO, Antonius Arnoldus Christiaan JACOBS
-
Publication number: 20190105385Abstract: The present invention pertains to a vaccine comprising in combination non-replicating immunogen of porcine circo virus type 2 and non-replicating immunogen of Mycoplasma hyopneumoniae and an adjuvant containing a nano-emulsion of mineral oil in water, for use in prophylactically treating an animal against an infection with porcine circovirus type 2 (PCV2) and an infection with Mycoplasma hyopneumoniae by administration of the vaccine into the dermis of the animal.Type: ApplicationFiled: March 22, 2017Publication date: April 11, 2019Applicant: Intervet Inc.Inventors: Melanie Sno, Maarten Hendrik Witvliet, Vicky Fachinger
-
Publication number: 20190099480Abstract: The present invention pertains to a vaccine comprising in combination non-replicating immunogen of porcine circo virus type 2 and live attenuated PRRS virus for use in prophylactically treating an animal against an infection with porcine circovirus type 2 (PCV2) and an infection with PRRS virus by administration of the vaccine into the dermis of the animal.Type: ApplicationFiled: March 22, 2017Publication date: April 4, 2019Applicant: Intervet Inc.Inventors: Melanie Sno, Maarten Hendrik Witvliet, Vicky Fachinger
-
Publication number: 20190091321Abstract: The present invention pertains to a vaccine for use in prophylactically treating an animal against an infection with porcine circovirus type 2 (PCV2) and an infection with PRRS virus, the vaccine comprising in combination non-replicating immunogen of porcine circovirus type 2 and live attenuated PRRS virus, wherein the vaccine additionally comprises albumin.Type: ApplicationFiled: March 22, 2017Publication date: March 28, 2019Applicant: Intervet Inc.Inventors: Melanie Sno, Pieter Gelder Van, Vicky Fachinger, Chen Shu-hui Tan
-
Patent number: 10130699Abstract: The present invention pertains to a vaccine comprising in combination killed whole cell Lawsonia intracellularis bacteria and porcine circo virus 2 (PCV2) ORF2 protein for use in protecting a pig against an infection with Lawsonia intracellularis and PCV2 by an intradermal administration of the vaccine. The invention also pertains to a method to protect a swine against an infection with Lawsonia intracellularis bacteria and PCV2.Type: GrantFiled: December 2, 2014Date of Patent: November 20, 2018Assignee: Intervet Inc.Inventors: Antonius Arnoldus Christiaan Jacobs, Vicky Fachinger, Melanie Sno, Maarten Hendrik Witvliet
-
Patent number: 10130698Abstract: The present invention pertains to a vaccine comprising a non-replicating immunogen of porcine circo virus type 2 for use in prophylactically treating an animal that has circulating antibodies directed against porcine circo virus type 2, against an infection with pathogenic porcine circo virus type 2 by a single dose administration of the vaccine into the dermis of the animal.Type: GrantFiled: December 2, 2014Date of Patent: November 20, 2018Assignee: Intervet Inc.Inventors: Vicky Fachinger, Melanie Sno, Maarten Hendrik Witvliet
-
Publication number: 20170157236Abstract: The present invention pertains to a vaccine comprising a non-replicating immunogen of porcine circo virus type 2 for use in prophylactically treating an animal that has circulating antibodies directed against porcine circo virus type 2, against an infection with pathogenic porcine circo virus type 2 by a single dose administration of the vaccine into the dermis of the animal.Type: ApplicationFiled: December 2, 2014Publication date: June 8, 2017Applicant: Intervet Inc.Inventors: Vicky Fachinger, Melanie Sno, Maarten Hendrik Witvliet
-
Publication number: 20160303218Abstract: The present invention pertains to a vaccine comprising in combination killed whole cell Lawsonia intracellularis bacteria and porcine circo virus 2 (PCV2) ORF2 protein for use in protecting a pig against an infection with Lawsonia intracellularis and PCV2 by an intradermal administration of the vaccine. The invention also pertains to a method to protect a swine against an infection with Lawsonia intracellularis bacteria and PCV2.Type: ApplicationFiled: December 2, 2014Publication date: October 20, 2016Applicant: Intervet Inc.Inventors: Antonius Arnoldus Christiaan Jacobs, Vicky Fachinger, Melanie Sno, Maarten Hendrik Witvliet
-
Publication number: 20150376577Abstract: The present invention relates to methods for the release of baculovirus-expressed Virus-like Particles (VLP's) of non-enveloped viruses from insect cells.Type: ApplicationFiled: February 14, 2014Publication date: December 31, 2015Applicant: INTERVET INC.Inventors: Vicky Fachinger, Melanie Sno
-
Patent number: 9193759Abstract: The present invention relates to methods for the release of baculovirus-expressed Virus-like Particles (VLP's) of non-enveloped viruses from insect cells.Type: GrantFiled: February 10, 2014Date of Patent: November 24, 2015Assignee: Intervet Inc.Inventors: Vicky Fachinger, Melanie Sno
-
Publication number: 20140234900Abstract: The present invention relates to methods for the release of baculovirus-expressed Virus-like Particles (VLP's) of non-enveloped viruses from insect cells.Type: ApplicationFiled: February 10, 2014Publication date: August 21, 2014Inventors: Vicky FACHINGER, Melanie SNO